Tahoe Forest cancer center joins CancerLinQ database
TRUCKEE, Calif. — The Gene Upshaw Memorial Tahoe Forest Cancer Center recently announced it’s joined CancerLinQ, a data initiative developed and led by the American Society of Clinical Oncology (ASCO) to help improve the overall quality of care for people with cancer.
Truckee’s cancer center is one of more than 75 practices that have signed agreements with CancerLinQ LLC, a wholly owned nonprofit of ASCO dedicated to the development and operation of the CancerLinQ system.
In the United States, approximately 1.7 million people are diagnosed each year with cancer, but only 3% enroll in clinical trials. Many important cancer treatment insights come from a small subset of clinical trial patients.
The CancerLinQ program connects and analyzes real-world cancer data from almost any medical record source, and provides real-time quality feedback, allowing physicians to compare their treatment plans against guidelines and care of their peers.
“At our Cancer Center,” said Laurence Heifetz, MD, FACP, Medical Director at the Gene Upshaw Memorial Tahoe Forest Cancer Center, “we are always open to new technologies that help us improve patient care, and the CancerLinQ database is a good fit for us.”
CancerLinQ allows cancer care providers to analyze millions of confidential cancer patient medical records, in order to analyze patterns and trends, and measure treatments against peers and recommended guidelines.
The CancerLinQ platform is the only effort of its kind driven by a nonprofit, physician organization. It leverages the combined expertise of more than 40,000 of the world’s leading oncologists who comprise ASCO’s membership.
CancerLinQ is supported in part through the Conquer Cancer Foundation, whose generous donors have helped make the system possible. Visit CancerLinQ.org to learn more.
This article was provided by Tahoe Forest Health System. Visit tahoecancercenter.com to tfhd.com to learn more.